Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNF472 in calciphylaxis
NCT04195906Phase 3Completed
- Sponsor
- Sanifit Therapeutics
- Start
- Feb 2020
- Primary completion
- Oct 2022
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of SNF472 in calciphylaxis (CUA), sponsored by Sanifit Therapeutics. Started Feb 2020; status: completed.
02
Drugs
SNF472
03
Conditions
calciphylaxis (CUA)
Beyond the preview
Go deeper on NCT04195906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04195906.